Scientists say there's no certain way to stop someone intent on monkeying with DNA, no matter what laws or standards are in place.
The dual-use nature of emerging biotechnology necessitates biosecurity measures in industry, particularly for the gene synthesis sector which produces DNA sequences to order.
Some scientists worry the startling claim will lead to knee-jerk regulations and damage the public’s trust in gene editing.
After researchers resurrected a long-dead pox, some critics argue that it's too easy for scientists to make decisions of global consequence.
The Trump administration wants to modernize the federal guidelines for companies that sell made-to-order DNA in hopes of keeping dangerous genetic material out of the hands of malicious potential customers.
Horsepox synthesis is more likely to occur when scientists act independently rather than as a group.
Most scientists in the world don't have comprehensive access to the scientific literature - even though it's all online.
This blog discusses synthetic biology research and issues impacting the field, such as biosecurity and governance.
This Strategy outlines the President's vision for addressing the challenges of biological weapons proliferation or their use by terrorists. The Strategy emphasizes the need to (1) improve global access to the life sciences to combat infectious disease regardless of its cause; (2) establish and reinforce norms against the misuse of the life sciences; and (3) institute a suite of coordinated activities that collectively will help influence, identify, inhibit, and/or interdict those who seek to misuse the life sciences.